Theravance Biopharma (TBPH)

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

O preço da ação Theravance Biopharma, Inc. Ordinary Shares (TBPH) after-hours hoje é de , refletindo uma movimentação de NaN% after-hours desde que o mercado fechou. A capitalização de mercado da empresa é de $ 959,99 mi, com um volume comercial diário de  ações. O preço de fechamento anterior foi .

Vamos começar? Siga os passos abaixo ou leia nosso guia sobre como comprar Theravance Biopharma ações na Kraken a partir de US$ 10.